Reynders McVeigh Capital Management LLC increased its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 13.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 560,733 shares of the technology company's stock after buying an additional 65,729 shares during the quarter. Relx accounts for approximately 1.3% of Reynders McVeigh Capital Management LLC's holdings, making the stock its 29th largest holding. Reynders McVeigh Capital Management LLC's holdings in Relx were worth $25,469,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Arrowstreet Capital Limited Partnership raised its position in shares of Relx by 50.3% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company's stock worth $89,420,000 after purchasing an additional 658,655 shares during the period. Envestnet Asset Management Inc. raised its holdings in Relx by 2.6% during the 4th quarter. Envestnet Asset Management Inc. now owns 1,898,927 shares of the technology company's stock worth $86,249,000 after buying an additional 48,336 shares during the period. Natixis Advisors LLC lifted its stake in Relx by 2.8% in the fourth quarter. Natixis Advisors LLC now owns 1,202,592 shares of the technology company's stock valued at $54,622,000 after buying an additional 32,739 shares in the last quarter. Raymond James Financial Inc. bought a new position in Relx in the fourth quarter valued at approximately $44,516,000. Finally, Bank of Montreal Can boosted its holdings in shares of Relx by 290.3% in the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company's stock valued at $40,277,000 after buying an additional 659,547 shares during the period. 15.02% of the stock is currently owned by institutional investors.
Relx Stock Up 2.8 %
Relx stock traded up $1.39 during mid-day trading on Tuesday, reaching $51.51. The company's stock had a trading volume of 718,780 shares, compared to its average volume of 718,726. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. Relx Plc has a 12 month low of $40.25 and a 12 month high of $51.99. The business's 50 day simple moving average is $49.30 and its 200 day simple moving average is $47.91. The company has a market capitalization of $95.33 billion, a price-to-earnings ratio of 27.69, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84.
Relx Increases Dividend
The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be issued a $0.5586 dividend. This is a boost from Relx's previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. Relx's dividend payout ratio (DPR) is presently 59.68%.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on RELX shares. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Redburn Atlantic initiated coverage on Relx in a report on Wednesday, January 8th. They issued a "buy" rating on the stock. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Finally, The Goldman Sachs Group began coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Relx currently has a consensus rating of "Buy".
Get Our Latest Stock Analysis on Relx
Relx Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
